SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001171843-18-006899
Filing Date
2018-10-05
Accepted
2018-10-05 16:32:56
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 f424b5_100518.htm 424B5 551164
2 GRAPHIC logo.jpg GRAPHIC 15718
3 GRAPHIC g454665g79g20.jpg GRAPHIC 8551
  Complete submission text file 0001171843-18-006899.txt   585849
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 424B5 | Act: 33 | File No.: 333-223464 | Film No.: 181110870
SIC: 2834 Pharmaceutical Preparations